HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

HSIC

Henry Schein, Inc. (S&P 500)

Healthcare — Medical Distribution

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Buy 2.4 / 5 15 analysts
$84.93
+$0.96 (+1.14%)
Target: $97.27 (14.5%)

Price History

52-Week Range
Sign in to add HSIC to a watchlist or set price alerts.

Fundamentals

Market Cap$9.47B
P/E Ratio (TTM)24.76
Forward P/E14.18
EPS (TTM)$3.43
Dividend Yield-
Profit Margin2.96%
Revenue Growth6.70%
ROE8.85%
Debt/Equity80.73
Recommendation Buy 2.4
Analyst Target$97.27
Analysts15
Next Earnings Aug 4, 2026 BMO
Indexes S&P 500

Technical Indicators

RSI (14)38.0
Beta0.81
SMA 20$86.78
SMA 40$88.07
52-Week High$92.18
52-Week Low$61.95
50-Day Avg$87.70
200-Day Avg$80.18
Avg Volume$1.20M
Volume$1.03M

Performance Analysis

BULLISH

HSIC shows predominantly bullish signals based on its fundamentals and technicals.

+ Showing strength at 76% of its 52-week range.
~ RSI at 38.0 is in neutral territory.
~ Price dropped below the 50-day average but remains above the 200-day — possible short-term weakness.
~ Modest revenue growth of 6.7% year-over-year.
+ Wall Street consensus is "Buy" from 15 analysts.
+ Average analyst target of $97.27 implies 14.5% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Oct 01, 2026 21:01 UTC

Back to Screener Export Report